122 related articles for article (PubMed ID: 8512490)
1. Photodynamic therapy of subretinal neovascularization in the monkey eye.
Miller H; Miller B
Arch Ophthalmol; 1993 Jun; 111(6):855-60. PubMed ID: 8512490
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
Potter MJ; Szabo SM; Chan EY; Morris AH
Am J Ophthalmol; 2002 Jan; 133(1):149-51. PubMed ID: 11755857
[TBL] [Abstract][Full Text] [Related]
3. [Selective occlusion of subretinal neovascularization with photodynamic therapy].
Schmidt-Erfurth U; Hasan T; Gragoudas E; Birngruber R
Ophthalmologe; 1994 Dec; 91(6):789-95. PubMed ID: 7849433
[TBL] [Abstract][Full Text] [Related]
4. Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.
Blumenkranz MS; Woodburn KW; Qing F; Verdooner S; Kessel D; Miller R
Am J Ophthalmol; 2000 Mar; 129(3):353-62. PubMed ID: 10704552
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of laser-induced choroidal subretinal neovascularization.
Miller H; Miller B; Ishibashi T; Ryan SJ
Invest Ophthalmol Vis Sci; 1990 May; 31(5):899-908. PubMed ID: 1692312
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES
Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental preretinal neovascularization using photodynamic thrombosis.
Wilson CA; Saloupis P; Hatchell DL
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2530-5. PubMed ID: 1714431
[TBL] [Abstract][Full Text] [Related]
8. [Clinical notes during photodynamic therapy for subretinal neovascularization].
Zolotarev AV; Malyshev AS; Fadeeva AV; Morozova IuV
Vestn Oftalmol; 2007; 123(6):43-6. PubMed ID: 18225527
[No Abstract] [Full Text] [Related]
9. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.
Smithen LM; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):884-5. PubMed ID: 15531339
[TBL] [Abstract][Full Text] [Related]
10. Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
De Lahitte GD; Cohen SY; Gaudric A
Am J Ophthalmol; 2004 Nov; 138(5):892-4. PubMed ID: 15531343
[TBL] [Abstract][Full Text] [Related]
11. [Dye laser photocoagulation treatment for experimental subretinal neovascularization. 2. Histopathological findings of unsuccess lesions].
Takahashi K; Itagaki T; Yamagishi K; Ohkuma H; Nishimura T; Uyama M
Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):810-9. PubMed ID: 2248166
[TBL] [Abstract][Full Text] [Related]
12. Exudative retinal detachment after photodynamic injury.
Wilson CA; Royster AJ; Tiedeman JS; Hatchell DL
Arch Ophthalmol; 1991 Jan; 109(1):125-34. PubMed ID: 1987930
[TBL] [Abstract][Full Text] [Related]
13. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
[TBL] [Abstract][Full Text] [Related]
14. Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs.
Danis RP; Yang Y; Massicotte SJ; Boldt HC
Arch Ophthalmol; 1993 Apr; 111(4):539-43. PubMed ID: 7682408
[TBL] [Abstract][Full Text] [Related]
15. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization.
Kliman GH; Puliafito CA; Stern D; Borirakchanyavat S; Gregory WA
Lasers Surg Med; 1994; 15(1):2-10. PubMed ID: 7527887
[TBL] [Abstract][Full Text] [Related]
16. A new method for vascular occlusion. Photochemical initiation of thrombosis.
Nanda SK; Hatchell DL; Tiedeman JS; Dutton JJ; Hatchell MC; McAdoo T
Arch Ophthalmol; 1987 Aug; 105(8):1121-4. PubMed ID: 3632422
[TBL] [Abstract][Full Text] [Related]
17. [A role of the retinal pigment epithelium in the involution of subretinal neovascularization].
Takahashi K; Itagaki T; Yamagishi K; Ohkuma H; Uyama M
Nippon Ganka Gakkai Zasshi; 1990 Apr; 94(4):340-51. PubMed ID: 1697726
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate.
Sakamoto T; Soriano D; Nassaralla J; Murphy TL; Oganesian A; Spee C; Hinton DR; Ryan SJ
Arch Ophthalmol; 1995 Feb; 113(2):222-6. PubMed ID: 7864756
[TBL] [Abstract][Full Text] [Related]
19. A new model of subretinal neovascularization in the rabbit.
Kimura H; Sakamoto T; Hinton DR; Spee C; Ogura Y; Tabata Y; Ikada Y; Ryan SJ
Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2110-9. PubMed ID: 7657549
[TBL] [Abstract][Full Text] [Related]
20. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
